- Mankind Pharma is likely to announce its share allotment status on May 3.
- The IPO received great demand from investors as the issue was subscribed 15.32 times.
- The shares will be listed on May 8 on NSE and BSE.
The ₹4,326 crore IPO received great demand from investors, with the issue being subscribed 15.32 times. The qualified institutional buyer portion was subscribed the most at 49.16 times.
The portion reserved for retail witnessed weak demand as it was subscribed just 0.92 times, while that of the non-institutional investors was subscribed 3.8 times.
Currently, shares of the condom maker are demanding a premium of ₹80 per share in the grey market. GMP is the premium at which IPO shares are traded in the unofficial market before they are listed on the stock exchanges.
The company’s shares will be listed on the stock exchanges on May 8.
The IPO was a complete offer for sale (OFS) of over 4 crore equity shares by the promoters and existing shareholders of the company. The company will not receive any proceeds from the offer.
The company sells Manforce condoms and Prega News pregnancy detection kits.
It manufactures a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Its wide range of offerings include condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations.
Here is how to check
- Go to the BSE website or NSE website here.
- On BSE, Select 'Equity' and then from the dropdown, select ‘Mankind Pharma’.
- Now, enter your application number and PAN.
- Click on 'Search'.
- Please note the details will only be available once the shares are allotted.
- Visit the registrar's website here.
- Click on 'Select company' and click on ‘Mankind Pharma’.
- Once the company is selected, you will have to enter either your PAN details, the application number, or the client ID.
- Enter the captcha code and click ’submit’.
SEE ALSO: